Dieses Human ELISA-Kit ist ein Colorimetric ELISA-Kit, das dafür entwickelt wurde, Human zu quantifizieren.
Produktnummer ABIN7666570
Kurzübersicht für SARS-CoV-2 N-Protein IgM Antibody ELISA Kit (ABIN7666570)
Target
SARS-CoV-2 N-Protein IgM Antibody
Reaktivität
Human
Nachweismethode
Colorimetric
Methodentyp
Indirect ELISA
Applikation
ELISA
Proben
Plasma, Serum
Verwendungszweck
anti-SARS-CoV-2 (NP) IgM - ELISA kit for the detection of IgM antibodies to nucleocapsid protein (NP) of coronavirus SARS-CoV-2, causing the COVID-19 disease in human serum and plasma isolated from venous or capillary blood.
Marke
ELISA-VIDITEST
Analytische Methode
Semi-Quantitative
Bestandteile
ELISA break-away strips in the handling frame coated with the antigen STRIPS Ag 1 x 12 pcs
1.3 mL Negative control serum, r.t.u. NC 1 vial
1.3 mL Positive control serum, r.t.u. PC 1 vial
1.3 mL Calibrator, r.t.u. 1) CAL 1 vial
13 mL Anti-human IgM antibodies labelled with horseradish peroxidase (anti-IgM Px conjugate) r.t.u. CONJ 1 vial
Optimal working dilution should be determined by the investigator.
Plattentyp
Pre-coated
Protokoll
anti-SARS-CoV-2 (NP) IgM is a solid-phase immunoanalytical test. The specific antigen (Nucleocapsid Protein) is fixed to each well of the microtiter strips. Specific antibodies present in the patient's sample are bound during the first incubation step. After removing unbound material by washing, the presence of the specific antibodies is detected using anti-human IgM conjugate during the second incubation. The unbound peroxidase conjugate is then removed and TMB substrate is added, resulting in the development of a blue colour in positive samples. The enzyme reaction is terminated by addition of the stop solution (colour change to yellow). The intensity of the yellow colour thus developed is proportional to the concentration of antibodies in the sample. 2